Epinephrine 0.3 MG auto-inject 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FRZG2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,516
Award facts
- Contract value 100% obligated
- $1,515.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,515.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector units. The delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial performance as a critical supplier within the federal pharmaceutical supply chain, leveraging its single-award IDC under the PPV-G GEN V program (contract SPE2DR, valued at $499,999,999 through December 31, 2036) to deliver an extensive portfolio of branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medications such as epinephrine auto-injectors. The company's consistent contract performance across multiple therapeutic categories and its competitive capability in unrestricted federal procurement have established it as a key regional prime vendor contractor supporting recurring medical supply needs for military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FRZG2?
SPE2DR26FRZG2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FRZG2 worth?
The government has obligated $1,516 on SPE2DR26FRZG2.
Is contract SPE2DR26FRZG2 an order under another contract?
Yes. SPE2DR26FRZG2 is a delivery order under SPE2DR25D9263, an indefinite delivery contract.
Was contract SPE2DR26FRZG2 competed?
The extent of competition for SPE2DR26FRZG2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award